Back to Search
Start Over
LONG-TERM EFFICACY AND SAFETY IN THE RESONATE STUDY: IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH UP TO FOUR YEARS FOLLOW-UP
- Source :
- Hematological Oncology. 35:235-236
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Chronic lymphocytic leukemia
Hematology
General Medicine
medicine.disease
03 medical and health sciences
chemistry.chemical_compound
030104 developmental biology
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
Internal medicine
Ibrutinib
medicine
In patient
business
Previously treated
Subjects
Details
- ISSN :
- 02780232
- Volume :
- 35
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........bf8d80b3d1449a63ba0cffe41684154a